Telehealth Encourages Patients with Diabetes in Racial and Ethnic Minority Groups to Return for in-Person Ophthalmic Care During the COVID-19 Pandemic

References

• Centers for Disease Control and Prevention. National diabetes statistics report, 2020. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Dept. of Health and Human Services; 2020. Available from: https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. Accessed October 30, 2020.
   Google Scholar
• Lin J, Thompson TJ, Cheng YJ, et al. Projection of the future diabetes burden in the United States through 2060. Popul Health Metr. 2018;16(1):9. doi:10.1186/s12963-018-0166-4
   PubMed Web of Science ®Google Scholar
• Roberts H, Jiles R, Mokdad A, Beckles G, Rios-Burrows N. Trend analysis of diagnosed diabetes prevalence among American Indian/Alaska native young adults–United States, 1994–2007. Ethn Dis. 2009;19(3):276–279.
   PubMed Web of Science ®Google Scholar
• Eberhardt MS, Casagrande SS, Cowie CC. Sociodemographic characteristics of persons with diabetes. In: Cowie CC, Casagrande SS, Menke A, et al. editors. Diabetes in America. 3rd ed. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases.; 2018. Chapter 8.
   Google Scholar
• Cheng YJ, Kanaya AM, Araneta MRG, et al. Prevalence of diabetes by race and ethnicity in the United States, 2011–2016. JAMA. 2019;322(24):2389–2398. doi:10.1001/jama.2019.19365
   PubMed Web of Science ®Google Scholar
• Varma R, Bressler NM, Doan QV, et al. Prevalence of and risk factors for diabetic macular edema in the United States. JAMA Ophthalmol. 2014;132(11):1334–1340. doi:10.1001/jamaophthalmol.2014.2854
   PubMed Web of Science ®Google Scholar
• Mayer-Davis EJ, Davis C, Saadine J, et al. Diabetic retinopathy in the SEARCH for diabetes in youth cohort: a pilot study. Diabet Med. 2012;29(9):1148–1152. doi:10.1111/j.1464-5491.2012.03591.x
   PubMed Web of Science ®Google Scholar
• Flaxel CJ, Adelman RA, Bailey ST, et al. Diabetic retinopathy preferred practice pattern®. Ophthalmology. 2020;127(1):P66–P145. doi:10.1016/j.ophtha.2019.09.025
   PubMed Web of Science ®Google Scholar
• Buse JB, Wexler DJ, Tsapas A, et al. 2019 update to: management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2020;43(2):487–493. doi:10.2337/dci19-0066
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BEK. Screening for diabetic retinopathy, revisited. Am J Ophthalmol. 2002;134(2):261–263. doi:10.1016/S0002-9394(02)01593-3
   PubMed Web of Science ®Google Scholar
• Lundeen EA, Wittenborn J, Benoit SR, Saaddine J. Disparities in receipt of eye exams among medicare part B fee-for-service beneficiaries with diabetes - United States, 2017. MMWR Morb Mortal Wkly Rep. 2019;68(45):1020–1023. doi:10.15585/mmwr.mm6845a3
   PubMed Web of Science ®Google Scholar
• Daskivich LP, Vasquez C, Martinez C, Tseng CH, Mangione CM. Implementation and valuation of a large-scale teleretinal diabetic retinopathy screening program in the Los Angeles County Department of Health Services. JAMA Intern Med. 2017;177(5):642–649. doi:10.1001/jamainternmed.2017.0204
   PubMed Web of Science ®Google Scholar
• Matsunaga DR, Salabati M, Obeid A, et al. Outcomes of eyes with diabetic macular edema that are lost to follow-up after anti-vascular endothelial growth factor therapy. Am J Ophthalmol. 2022;233:1–7. doi:10.1016/j.ajo.2021.06.028
   PubMed Web of Science ®Google Scholar
• Obeid A, Su D, Patel SN, et al. Outcomes of eyes lost to follow-up with proliferative diabetic retinopathy that received panretinal photocoagulation versus intravitreal anti-vascular endothelial growth factor. Ophthalmology. 2019;126(3):407‐413. doi:10.1016/j.ophtha.2018.07.027
   Web of Science ®Google Scholar
• Obeid A, Gao X, Ali FS, et al. Loss to follow-up in patients with proliferative diabetic retinopathy after panretinal photocoagulation or intravitreal anti-VEGF injections. Ophthalmology. 2018;125(9):1386–1392. doi:10.1016/j.ophtha.2018.02.034
   PubMed Web of Science ®Google Scholar
• Ramsey DJ, Arden GB. Hypoxia and dark adaptation in diabetic retinopathy: interactions, consequences, and therapy. Curr Diab Rep. 2015;15(12):118. doi:10.1007/s11892-015-0686-2
   PubMed Web of Science ®Google Scholar
• Aziz K, Moon JY, Parikh R, et al. Association of patient characteristics with delivery of ophthalmic telemedicine during the COVID-19 pandemic. JAMA Ophthalmol. 2021;139(11):1174–1182. doi:10.1001/jamaophthalmol.2021.3728
   PubMed Web of Science ®Google Scholar
• Elam AR, Sidhom D, Ugoh P, et al. Disparities in eye care utilization during the COVID-19 Pandemic. Am J Ophthalmol. 2021;233:163–170. doi:10.1016/j.ajo.2021.07.024
   PubMed Web of Science ®Google Scholar
• Acosta AM, Garg S, Pham H, et al. Racial and ethnic disparities in rates of COVID-19-associated hospitalization, intensive care unit admission, and in-hospital death in the United States from March 2020 to February 2021. JAMA Netw Open. 2021;4(10):e2130479. doi:10.1001/jamanetworkopen.2021.30479
   PubMed Web of Science ®Google Scholar
• Chodosh J, Holland GN, Yeh S. Important coronavirus updates for ophthalmologists. American Academy of Ophthalmology; 2020. Available from: https://www.aao.org/headline/alert-important-coronavirus-context. Accessed May 26, 2020..
   Google Scholar
• Sethi K, Levine ES, Roh S, Marx JL, Ramsey DJ. Modeling the impact of COVID-19 on retina clinic performance. BMC Ophthalmol. 2021;21(1):206. doi:10.1186/s12886-021-01955-x
   PubMed Web of Science ®Google Scholar
• Longworth D. Memo to Lahey Hospital & Medical Center medical staff colleagues and leaders. COVID-19 updates: guidance on curtailment of elective procedures and visits; 2020.
   Google Scholar
• Commonwealth of Massachusetts. Department of Public Health. Mass.gov. COVID-19 response reporting; 2021. Available from: https://www.mass.gov/info-details/covid-19-response-reporting. Accessed November 2, 2021.
   Google Scholar
• Robbins CC, Anjum S, Alwreikat AM, et al. An initiative to improve follow-up of patients with glaucoma. Ophthalmol Sci. 2021;1(4):100059. doi:10.1016/j.xops.2021.100059
   PubMedGoogle Scholar
• Elam AR, Andrews C, Musch DC, Lee PP, Stein JD. Large disparities in receipt of glaucoma care between enrollees in Medicaid and those with commercial health insurance. Ophthalmology. 2017;124(10):1442–1448. doi:10.1016/j.ophtha.2017.05.003
   PubMed Web of Science ®Google Scholar
• Halawa OA, Kolli A, Oh G, et al. Racial and socioeconomic differences in eye care utilization among Medicare beneficiaries with glaucoma. Ophthalmology. 2022;129(4):397–405. doi:10.1016/j.ophtha.2021.09.022
   PubMed Web of Science ®Google Scholar
• Malhotra NA, Greenlee TE, Iyer AI, Conti TF, Chen AX, Singh RP. Racial, ethnic, and insurance-based disparities upon initiation of anti-vascular endothelial growth factor therapy for diabetic macular edema in the US. Ophthalmology. 2021;128(10):1438–1447. doi:10.1016/j.ophtha.2021.03.010
   PubMed Web of Science ®Google Scholar
• Shi Q, Fonseca V, Krousel-Wood M, et al. Will the Affordable Care Act (ACA) improve racial/ethnic disparity of eye examination among US working-age population with diabetes? Curr Diab Rep. 2016;16(7):58. doi:10.1007/s11892-016-0749-z
   PubMed Web of Science ®Google Scholar
• Pang Y, Ren Z, Wang J, Wilson FA. Impact of the affordable care act on utilization of benefits of eye care and primary care examinations. PLoS One. 2020;15(11):e0241475. doi:10.1371/journal.pone.0241475
   PubMed Web of Science ®Google Scholar
• Ahmed I, Liu TYA. The Impact of COVID-19 on diabetic retinopathy monitoring and treatment. Curr Diab Rep. 2021;21(10):40. doi:10.1007/s11892-021-01411-6
   PubMed Web of Science ®Google Scholar
• Press release: baker-polito administration announces emergency actions to address COVID-19; 2020. Available from: https://www.mass.gov/news/baker-polito-administration-announces-emergency-actions-to-address-covid-19. Accessed April 28, 2020.
   Google Scholar
• Mass.gov. Office of Governor Charlie Baker and Lt. Governor Karyn Polito. Press release. Governor Charlie Baker orders all non-essential businesses to cease in person operation, directs the department of public health to issue stay at home advisory for two weeks. Commonwealth of Massachusetts; 2020. Available from: https://www.mass.gov/news/governor-charlie-baker-orders-all-non-essential-businesses-to-cease-in-person-operation. Accessed March 13, 2021.
   Google Scholar
• Centers for Medicare & Medicaid Services. Medicare telemedicine health care provider fact sheet; 2020. Available from: https://www.cms.gov/newsroom/fact-sheets/medicare-telemedicine-health-care-provider-fact-sheet. Accessed November 24, 2021.
   Google Scholar
• National Academies of Sciences, Engineering, and Medicine. The state of health disparities in the United States. In: Baciu A, Negussie Y, Geller A, et al. editors. Communities in Action: Pathways to Health Equity. Washington, DC: The National Academies Press; 2017. Chapter 2.
   Google Scholar
• Jones N, Marks R, Ramirez R, Rios-Vargas M. 2020 Census illuminates racial and ethnic composition of the country. United States Census Bureau, Population Division; 2021. Available from: https://www.census.gov/library/stories/2021/08/improved-race-ethnicity-measures-reveal-united-states-population-much-more-multiracial.html. Accessed November 4, 2021.
   Google Scholar
• Commonwealth of Massachusetts. Office of the Governor. Executive Order. Order expanding access to telehealth services and to protect health care providers; 2020. Available from: https://www.mass.gov/doc/march-15-2020-telehealth-order/download. Accessed December 6, 2021.
   Google Scholar
• Mass.gov. Executive Office of Housing and Economic Development. Office of Charlie Baker and Lt. Governor Karyn Polito. Reopening Massachusetts. Commonwealth of Massachusetts; 2020. Available from: https://www.mass.gov/info-details/reopening-massachusetts. Accessed November 23, 2021.
   Google Scholar
• Oliver SE, Gargano JW, Marin M, et al. The advisory committee on immunization practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine – United States, December 2020. MMWR. 2020;69(50):1922–1924. doi:10.15585/mmwr.mm6950e2
   PubMed Web of Science ®Google Scholar